Black Book 2026 Payer Digital Technology Survey Establishes Rigorous 18-KPI Standard for Health Plan IT Client Satisfaction Rankings

May 29, 2026 3:30 PM

Black Book Research's 2026 State of Payer Digital Technology: Managed Care and Health Plans report introduces an industry-centric 18-KPI client satisfaction model for evaluating payer IT vendors, platforms, managed services, BPaaS providers, and technology-enabled operating partners across the modern health plan enterprise.Across the 2025-2026 study cycle, 8,194 verified managed care and health plan respondents evaluated payer technology...

Read more

Dr. Ran Rubinstein Brings BioRePeel to Newburgh, NY and Montvale, NJ

May 29, 2026 2:00 PM

Dr. Ran Rubinstein, double board-certified facial plastic surgeon, has added BioRePeel to the skin rejuvenation menu at both of his practices. Patients in the Hudson Valley can now book the treatment at Laser & Cosmetic Surgery Specialists, PC in Newburgh, New York, and patients in northern New Jersey can do the same at Rubinstein Plastic Surgery Center in Montvale. A New Option for Patients Who Want Results Without the DowntimeBioRePeel is a...

Read more

Aetna Better Health(R) of West Virginia Opens New Community Resource Center in Clarksburg

May 29, 2026 9:00 AM

Originally published on CVS Health Company NewsroomAetna Better Health® of West Virginia, a CVS Health® company (NYSE:CVS), announced the opening of a new Community Resource Center (CRC) located within the Community Care of West Virginia's Clarksburg facility. Open to the public, the center provides access to supportive health-related resources and a welcoming space for community meetings.The CRC plans to host wellness events and vaccine clinics...

Read more

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology

May 29, 2026 8:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,624,066 B2, titled "Compounds and Methods for Treatment of Coronavirus Infection." The newly granted patent protects Sunshine Biopharma's proprietary therapeutic compounds designed to inhibit...

Read more

MMJ International Holdings Files Formal Challenge To DEA Marijuana Rescheduling As Constitutional, Treaty, And Pharmaceutical Questions Collide

May 29, 2026 6:00 AM

MMJ International Holdings, ("MMJ"), together with its subsidiaries MMJ BioPharma Cultivation, and MMJ BioPharma Labs, announced today that it has formally entered the Drug Enforcement Administration's June 29, 2026 marijuana rescheduling hearing with a sweeping legal challenge raising constitutional, treaty, statutory, and pharmaceutical-regulatory objections to the federal government's proposed transfer of marijuana from Schedule I to Schedule...

Read more

Hemogenyx Pharmaceuticals PLC Announces Grant of Options and Extension of Warrant Term

May 29, 2026 4:50 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO), a clinical-stage biopharmaceutical group focused on developing treatments for cancers and viral diseases, announces the grant of share options and a variation to the exercise period for certain investor warrants.Grant of Share OptionsThe Board of Directors has agreed to grant options over a total of 1,200,000 ordinary shares of 1p each in the capital of the Company ("Board Share Options") to the...

Read more

ClinicsSpots Highlights Best-Rated Online Medical Assistant Programs for 2026

May 29, 2026 12:10 AM

For 2026, the best-rated online medical assistant programs are the ones that combine flexible coursework with clear certification preparation, verified clinical practice opportunities, transparent costs, student support, and curriculum coverage of both clinical and administrative skills. ClinicsSpots and many other top platforms consider Medical Prep fits into this discussion as an educational resource that helps learners understand medical...

Read more

Cantargia AB to Host Webcast Covering Rights Issue, Loan Agreement, and Strategic Priorities

May 28, 2026 3:35 PM

Cantargia (STO:CANTA) - With reference to the Company's press release on May 28, 2026, regarding the decision to conduct a rights issue in combination with a loan, Cantargia AB (Publ) ("Cantargia" or the "Company") invites shareholders, analysts and the press to a live web cast on June 1, 2026, at 4 pm CEST with details below."This rights issue strengthens our ability to deliver on nadunolimab's full potential," said Hilde Steineger, CEO of...

Read more

The Naderi Center for Plastic Surgery Weighs In on What the Public Gets Wrong About Deep Plane Facelift Techniques and Longevity

May 28, 2026 1:00 PM

In response to widespread online speculation surrounding celebrities and facelift procedures, Dr. Shervin Naderi, a double board-certified specialist in facial plastic surgery at The Naderi Center for Plastic Surgery, is providing his professional insight into what truly matters when performing a facelift procedure.As discussions about facelifts surge across social media platforms, many surgeons and commentators have debated the techniques,...

Read more

Cercare Medical Receives FDA 510(k) Clearance for Cone-Beam CT Perfusion

May 28, 2026 11:00 AM

Cercare Medical, a leader in advanced neuroimaging software, today announced FDA 510(k) clearance (K253831) for its Cone-Beam CT (CBCT) Perfusion solution, enabling qualitative perfusion assessment directly from cone-beam CT data acquired during neurointerventional procedures.The clearance marks an important step forward in acute stroke imaging by bringing advanced perfusion analysis directly into the angio suite, allowing clinicians to assess...

Read more

MilliporeSigma's Approach to Embedding Sustainability Earlier in Product Development

May 28, 2026 11:00 AM

For MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, sustainability isn't treated as a standalone initiative. It's increasingly embedded across the product life cycle, from early R&D decisions to sourcing, manufacturing, packaging, distribution, customer use, and end of life.The most meaningful opportunities to reduce environmental impact happen when product teams are still making foundational design...

Read more

Two Sides of the "Gift of Life" From DaVita Teammates

May 28, 2026 11:00 AM

Experiencing kidney disease can change one's entire perspective on life, and for some it can spark a mission to help others navigate that same journey. As we reflect on the impact of organ donation, DaVita honors teammates who have experienced the transplant process from two profoundly different yet connected sides: as a transplant recipient and as a living donor.Building on Personal Experience to Find a Fulfilling Career: Chris's JourneyChris...

Read more

Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders

May 28, 2026 10:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) and family company Napo Pharmaceuticals (Napo) today highlighted how the Company's long-standing research in ethnobotanical medicine, sustainable harvesting, and regulatory drug development under botanical guidance ("botanical drug") continues to inform the development of crofelemer as a novel oral adjunctive therapy to PS for rare congenital gastrointestinal intestinal failure (IF) disorders, including...

Read more

SoCal Aesthetic Surgery Named "Best of 2026" by BusinessRate for Excellence in Plastic Surgery

May 28, 2026 10:00 AM

SoCal Aesthetic Surgery, a facial plastic surgery practice based in Irvine, California, has been named a "Best of 2026" award winner by BusinessRate. The recognition highlights the practice's strong reputation among patients and its consistently positive feedback across verified online review platforms.The award places SoCal Aesthetic Surgery among a select group of businesses recognized for maintaining high levels of customer satisfaction and...

Read more

Will Physicians Risk Their Licenses For CMS Hemp Products The FDA Never Approved?

May 28, 2026 9:50 AM

Judge Trevor McFadden dismissed the challenge to CMS's Substance Access Beneficiary Engagement Incentive (BEI) program on standing grounds, ruling that no plaintiff had demonstrated a sufficiently concrete injury.But in doing so, the court may have unintentionally revealed something far more important: If the judiciary will not intervene yet, and CMS has chosen to move forward without FDA approval standards, then the burden of protecting...

Read more

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing

May 28, 2026 9:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, today announced a one for ten reverse split of its common stock, effective at market open on June 1, 2026. The reverse stock split was undertaken to regain compliance with Nasdaq's minimum bid price requirement for continued listing. The reverse stock split will reduce the Company's issued and...

Read more

Medical Care Technologies (OTC PINK:MDCE) Provides Additional Details Regarding MDCE Melanoma Scan Beta Imaging Platform

May 28, 2026 8:47 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology company focused on AI-powered imaging and wellness applications, today provided additional details regarding the design framework and development objectives of its MDCE Melanoma Scan Beta platform. The beta-stage platform is being developed as an AI-assisted imaging and body-map monitoring application intended to support image organization and long-term...

Read more

Patient Safety Movement Foundation Appoints Three Distinguished Leaders to Governance Board

May 28, 2026 8:45 AM

The Patient Safety Movement Foundation (PSMF) today announced the appointment of three distinguished global leaders to its Governance Board: Rt. Hon. Sir Jeremy Hunt, MP, who served as the United Kingdom's Chancellor of the Exchequer from 2022 to 2024, and a former Minister of Health; Prof. Dr. Klaus Markstaller, Medical Director and Chairman of the Executive Board at the University Hospital of Augsburg; and Margaret-Mary Wilson, MD, Executive...

Read more

TRNR Updates Investor Presentation Detailing Acquisition Strategy and Increased M&A Pipeline

May 28, 2026 8:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, FORME and Ergatta brands, today published an updated investor presentation detailing its acquisition-driven operating strategy, the contribution of recently completed acquisitions, and an increased M&A pipeline.The updated presentation reflects the Company's transformation through the Wattbike and Ergatta...

Read more

Aspire Biopharma Issues Shareholder Letter

May 28, 2026 8:30 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today issued the following letter to shareholders from Chief Executive Officer Kraig Higginson.Dear Fellow Shareholders,2026 is shaping up to be a defining year for Aspire Biopharma Holdings. We are moving with speed to transform our clinical pipeline into commercial reality,...

Read more